Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 4Active not recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Vascular Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Tongue Neoplasms 1Tobacco Use Disorder 1Stomach Neoplasms 1Solid Tumor, Adult 1Prostatic Neoplasms 1Neoplasms 1Mouth Neoplasms 1MR-PET Imaging 1Hip Fractures 1Endometrial Neoplasms 1Colorectal Neoplasms 1Bone Cysts, Aneurysmal 1Bone Cysts 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 60Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × X-Rays × Clear all
NCT04535401 2024-10-10

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

National Cancer Institute (NCI)

Phase 1 Unknown
10 enrolled
Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡